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Management of Acute GI Bleeding in Patients Who Refuse Blood or Blood
Products
Abstract
Background and Significance: The Gastroenterology consult service evaluates patients who are admitted
to the hospital with gastrointestinal (GI) tract bleeding. Prompt endoscopic evaluation is the mainstay for
the diagnosis and treatment of clinically significant GI tract bleeding and occurs in concert with the
initiation of supportive measures, including replacement of lost blood, correction of coagulopathy,
treatment of hemorrhagic shock, and stimulation of erythropoiesis. There have been several case reports
of patients who exsanguinated from acute GI tract bleeding due to refusal of blood or blood products on
religious grounds. Management of such patients presents many treatment and ethical challenges. The
Jehovah's Witnesses population literally interprets the Bible passages Genesis 9:4, "But flesh with the life
thereof, which is the blood thereof, shall ye not eat." and Leviticus 17: 15, "And every soul that eateth that
which died of itself, or that which was torn with beasts, whether it be one of your own country, or a
stranger, he shall both wash his clothes, and bathe himself in water, and be unclean until the even: then
shall he be clean." to mean that they should not ingest blood and thus they do not accept blood or blood
products. Nonetheless, there are alternatives, albeit limited, to transfusion of human blood products for
patients with acute blood loss secondary to GI tract bleeding. For example, research studies have
demonstrated favorable outcomes following the use of recombinant factor Vila to treat anemia and
achieve hemostasis (Boffard et. Al, 2005). In addition, as noted by Berend and Levi (2009), there are
several unique lessons to be learned from the management of Jehovah's Witnesses with GI tract bleeding,
including learning how to seek and utilize alternative treatment options, and understand medical views
and beliefs of patients from different cultures and religions. To date, there are no published guidelines
that address the management of patients who refuse transfusion of blood or blood products for faithbased reasons. Purpose: To develop an evidence-based treatment protocol for the management of
patients who refuse transfusion of blood or blood products for faith-based reasons. Methods: Current
evidence was appraised and comparisons were made among the various treatment options for patients
who refuse transfusion of blood or blood products for faith-based reasons. Using critical appraisal and
synthesis, research studies were scored and beneficial interventions from high-quality studies were
incorporated into the evidence-based treatment protocol. Practice recommendations were then organized
into a treatment algorithm. Analyses: The algorithm was critiqued by an expert review panel and
subsequently revised based on its comments and recommendations. The revised algorithm will be
presented to the panel for final approval. Implications: This treatment algorithm will provide clinicians
with an evidence-based guide for the medical management of patients who refuse transfusion of blood or
blood product.
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Evidence Based Protocol: Management of Acute GI Bleeding in Patients Who Refuse Blood
or Blood Products
Abstract

Background and Significance: The Gastroenterology consult service evaluates patients who are
admitted to the hospital with gastrointestinal (GI) tract bleeding. Prompt endoscopic evaluation
is the mainstay for the diagnosis and treatment of clinically significant GI tract bleeding and
occurs in concert with the initiation of supportive measures, including replacement of lost blood,
correction of coagulopathy, treatment of hemorrhagic shock, and stimulation of erythropoiesis.
There have been several case reports of patients who exsanguinated from acute GI tract bleeding
due to refusal of blood or blood products on religious grounds. Management of such patients
presents many treatment and ethical challenges.
The Jehovah's Witnesses population literally interprets the Bible passages Genesis 9:4, "But
flesh with the life thereof, which is the blood thereof, shall ye not eat." and Leviticus 17: 15,
"And every soul that eateth that which died of itself, or that which was torn with beasts, whether
it be one of your own country, or a stranger, he shall both wash his clothes, and bathe himself in
water, and be unclean until the even: then shall he be clean." to mean that they should not ingest
blood and thus they do not accept blood or blood products. Nonetheless, there are alternatives,
albeit limited, to transfusion of human blood products for patients with acute blood loss
secondary to GI tract bleeding. For example, research studies have demonstrated favorable
outcomes following the use of recombinant factor Vila to treat anemia and achieve hemostasis
(Boffard et. Al, 2005). In addition, as noted by Berend and Levi (2009), there are several unique
lessons to be learned from the management of Jehovah's Witnesses with GI tract bleeding,
including learning how to seek and utilize alternative treatment options, and understand medical
views and beliefs of patients from different cultures and religions.
To date, there are no published guidelines that address the management of patients who refuse
transfusion of blood or blood products for faith-based reasons.

Purpose: To develop an evidence-based treatment protocol for the management of patients who
refuse transfusion of blood or blood products for faith-based reasons.
Methods: Current evidence was appraised and comparisons were made among the various
treatment options for patients who refuse transfusion of blood or blood products for faith-based
reasons. Using critical appraisal and synthesis, research studies were scored and beneficial
interventions from high-quality studies were incorporated into the evidence-based treatment
protocol. Practice recommendations were then organized into a treatment algorithm.
Analyses: The algorithm was critiqued by an expert review panel and subsequently revised based
on its comments and recommendations. The revised algorithm will be presented to the panel for
final approval.
Implications: This treatment algorithm will provide clinicians with an evidence-based guide for
the medical management of patients who refuse transfusion of blood or blood product

Introduction
The gastroenterology service at many major medical centers is often consulted when a
patient presents with gastrointestinal (GI) bleeding. They are responsible for making
recommendations that affect patient care and outcomes. There have been several reports of
patients who experienced an episode of acute bleeding from the GI tract (acute GI bleed), that
have expired because the patient adhered to this faith community's doctrine of refusal of blood
transfusion.
This project was developed as a performance improvement project to help improve
clinical management of patients who refuse transfusion of blood or blood products for faithbased reasons. An evidence-based treatment algorithm was developed using the most current
information to ensure that clinicians manage this patient population consistently and
appropriately, and that every treatment option and alternative is presented to patients. This
treatment algorithm will be used as a reference for providers on the gastroenterology service to
employ best practice during consultations involving treatment recommendations for this complex
patient population.
Jehovah's Witnesses are a group of individuals who began as a Bible study group in
1869. Part of the charge of their Bible study group was to extensively analyze various Biblical
readings. They found what they characterized as multiple errors in the traditional Christian
doctrine, including those related to Christian teachings. Thus, the religious convictions of this
following were based on strict literal interpretation of the Bible. In 1931, they adopted the name
Jehovah's Witnesses, which is based on Isaiah 43:10-12. There are over 6.7 million members
currently worldwide (Huges, Ullery, & Barie, 2008).

The Jehovah's Witnesses literally interpreted the following Biblical passages: "The one
thing you must not eat is meat with blood still in it; I forbid this because the life is in the blood"
(Genesis 9:4) and "The life of every living thing is in blood, and that is why the LORD has told
people of Israel that they shall not eat any meat with blood still in it and that anyone who does so
will no longer be considered one of his people" (Leviticus 17: 15). These passages explain and
provide rationale for why this population refuses blood and blood products. The people of the
Jehovah's Witness faith community are permitted to make the decision based on their own
conscious thought, but if they do decide to accept blood or blood products, there is a formal
process of "de-fellowship" that is instituted by the church itself (Effa-Heap, 2009). When taking
responsibility for the care of a Jehovah's Witness patient, it is important for clinicians to
understand why they feel so strongly about this issue. Consequently, as providers, we should
present to them all of the treatment options available and respect the choices that they make.
Boffard et. al (2005) conducted two parallel randomized, placebo-controlled, doubleblind clinical trials. The investigators used recombinant factor VIIa as adjunctive therapy for
bleeding control in severely injured trauma patients. Red blood cell (RBC) transfusion was
significantly reduced with rFVIIa relative to placebo and the need for massive transfusion. In
penetrating trauma, similar analyses showed trends toward rFVIIa reducing RBC transfusion and
massive transfusion. Mortality rate and critical complications also were reduced. These findings
provide evidence for the use of rFVIIa in the reduction of RBC transfusion in severe blunt
trauma (Boffard, et. Al., 2005).
The use of Recombinant Factor VIIa ( rFVIIa) was also supported via two case reports
regarding treatment of excessive bleeding in Jehovah's Witness patients following cardiac
surgery (Tanaka, Waly, Cooper, & Levy, 2003). Findings revealed that hemostasis (cessation of

bleeding) was improved in a cardiac surgical patient who refused blood products. Because no
human protein or derivatives were present during the manufacturing or purification process of
recombinant factor VIIa in baby hamster kidney cells, rFVIIa was found to be an acceptable
treatment option for these patients. These case reports provide further evidence on alternative
therapeutic options for this patient population.
The Jehovah's Witness patient population may be very challenging to clinically manage
because they refuse mainstream treatment options even at times when they face a life or death
choice. Berend and Levi (2009) noted that there are lessons to be learned from the management
of Jehovah's Witnesses, including acquisition of skills to seek alternatives to obvious treatments,
and seeking to understand views and beliefs of patients from different cultures. Having a tool in
a medical decision tree format to guide treatment of these patients will help providers stay
focused and consistent in their approach.
The purpose of this Performance Improvement project was to develop an evidence-based
treatment protocol to clinically manage patients who refuse transfusion of blood or blood
products for faith-based reasons.

Methods
An extensive updated review of literature was conducted through online databases using the
University of Rochester Medical Center Miner Library and St. John Fisher College Lavery
Library online resources. Further assistance was requested, as needed, from a dedicated health
studies librarian, at Lavery Library, St. John Fisher College.
Current evidence was appraised and comparisons were made among the various management
options for patient who refuse transfusion of blood or blood products for faith-based reasons.

Using the techniques of critical appraisal and synthesis, literature was scored and decisions were
made whether to incorporate resulting research evidence into the new evidence-based treatment
protocol.
Research gathered during the literature search was organized into an algorithm type flow
chart. This algorithm will be available to give providers a decision tree approach to medical
management of a patient who refuses transfusion of blood or blood products. The evidence
based protocol was then critiqued by expert review including one gastroenterology Attending,
one gastroenterology Fellow and two Advanced Practice Registered Nurses. They were asked to
critique the protocol for usability, adherence to current practice guidelines and compliance with
provider scope recommendations.
Outcomes

Listed below are the questions asked during the review process,
I. Does this protocol follow current practice guidelines?
2. Does it seem practical for use when treating this patient population?
3. Could this protocol be used by Fellows, Residents, NP/CNS's, PA's?
4. Recommended changes
5. Comments
All of the expert reviewers felt this performance improvement project will be essential
for treating this patient population. They stated that the recommendations follow current
evidence, it was easy to use and could be used across the interdisciplinary team. One of the
APRN reviewers stated "This shows the many things we still have available in our toolbox.", "I

would add this to my clinical pearls." The experts had minor spelling and layout
recommendations.
One of the APRN reviewers stated "I think that this protocol has the potential to provide
us with alternatives for the management of patient's with gastrointestinal bleeds that are
Jehovah's witnesses, but also helps us to find alternatives to blood products when there is such a
significant shortage of blood products available for all of our patients". This protocol is intended
for use by any provider that comes in contact with the situation that their patient refuses blood
transfusions. It is meant to give providers ideas of ways to manage this patient population and it
could most certainly be used when there is a shortage of blood products available to make sure
we are using all of the current evidence to treat the patients.

Changes
One of the changes that were made in tlie protocol was contacting the Jehovah's Witness
liaison committee. The literature had recommended contacting a member of this committee to
give providers support during management of this patient. The inclusion of the liaison committee
contact would be beneficial in maintaining an open relationship with the patient and the
providers. It would demonstrate that health care providers were taking all of the necessary steps
to ensure cultural competence. This protocol was developed for use in any department treating a
population who refuses blood or blood products. Many hospitals may not have a Jehovah's
Witness liaison committee. This may add more confusion to the protocol. Another performance
improvement project should be considered to develop a Jehovah's Witness Liaison committee.
This would serve as a great resource for any community so that this patient population feels
comfortable being treated at different medical facilities.

Discussion

When developing a protocol it is also important to think about possible barriers to
implementation. The APRN reviewer discussed possible barriers to implementing this protocol
which included the availability of the gastroenterology staff to be able to perform the procedures
in an expedited fashion, the availability of the closed circuit blood salvage equipment and the
overall willingness of the patient to accept the treatment plan and provide consent. Most large
medical facilities have an on-call gastroenterology service. For emergency procedures the
endoscopy team must respond to cases within one hour. The use of the closed circuit blood
salvage equipment was removed from the protocol. The protocol is developed to assist a provider
in initiating care when they are faced with the new patient situation. Using the closed circuit
blood salvage equipment would require surgical consult, more research of literature and a more
in-depth protocol. The development of an additional protocol utilizing the closed circuit blood
salvage equipment separate from this protocol may be helpful.
It is crucial that health care providers develop a trusting relationship with their health care

providers. With trusting professional relationships, patients may be more likely to actively
participate in the health care recommendations offered. Providers with background knowledge
about this specific patient population will be able to discuss treatment options that follow the
patient's religious practices.
Recommendations
Based on expert review this protocol is easy to use and it should be used across the
interdisciplinary team for the treatment of this patient population. The protocol follows current
evidence and recommended practice guidelines. This protocol could be disseminated to the
gastroenterology service at any major medical center. This would also be useful in emergency

.

department care, where care for hypovolemic shock from bleeding is most frequently initiated.

Management of Acute GI Bleeding
in Patients Who Refuse Blood or
Blood Products

Consider GI +/-

Early
transfer to
capable
hospital

Hematology
consult while
awaiting
transfer

Page the GI Fellow on call
Consider Hematology Consultation
Determine if ICU level of care is needed

Immediate treatment

Stimulate

Prompt arrest

Supportive

Erythro-

of bleeding

Measures

poiesis

>Endoscopy
>Antifibrinolytics (aminocaproic
acid or tranexamic acid)
>Tolerate hypotension (SBP>85)
>PPI drip
>Octreotide drip (if concern
for varicies)

>Conservative use of
moderately warm IV fluid
for hypotension
>Maximize oxygenation
>Vasopressors

>Erythropoietin
>Iron
>Folic Acid
>Vit B12

>Recombinant
factor VIia

>Limit diagnostic phlebotomy
(use pediatric vaccutianer
tube if available)
>Decrease metabolic rate
(maintain normothermia,
control rigors, treat agitation)

Recurrent or ongoing hemorrhage

Recurrent hemorrhage

>Discuss reconsidering blood
transfusion with patient
>Repeat emergent endoscopy or
colonoscopy

Hemostasis Achieved

>Close observation
>Continue IV PPI drip if peptic
ulcer hemorrhage
>+/- octreotide drip

Hemostasis Not Achieved

Ongoing hemorrhage

>+/-Tagged RBC scan
>IR consultation for angiography with
selective embolization
>Surgical consultation for refractory
bleeding
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